Alberta Health Services

Edmonton, Alberta T6K 4C1

1 studies enrolling now · 9 studies all time

What they study most

Alström Syndrome (AS), Amyloidosis, Any Solid Tumor With an EZH2 GOF Mutation, Atrial Fibrillation, Atypical Teratoid Rhabdoid Tumors (ATRT), Bardet Biedl Syndrome (BBS), Bardet-Biedl Syndrome, Calcium Release Deficiency Syndrome (CRDS), Cardiac Surgery, Epithelioid Sarcoma, INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary

Studies at this site

• Evaluation of A Clinical Diagnostic Test for CRDS — Recruiting now
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Pegcetacoplan Long Term Safety and Efficacy Extension Study — Completed
• A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis — Completed
• A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma — Completed
• Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway — Completed
• Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity — Completed
• Transfusion Requirements in Cardiac Surgery — Completed